The new grants will continue to advance PH research from the early exploratory stages to career development, transitioning new faculty-level investigators to established, independent investigators.
Silver Spring, Md. (PRWEB) May 15, 2015
The Pulmonary Hypertension Association (PHA) approaches its 25th Anniversary in 2016 as the nation’s leader in funding scientific research investigating ways to prevent and cure pulmonary hypertension (PH). PHA seeks applicants for its first round of 2015 research awards as it marks two decades of PH research support exceeding $15 million.
PHA research grants have supported more than 70 investigators in eight funding focus areas. PHA credits the generous support for these grants from PH patients, caregivers and other donors and collaborations with organizations such as the National Heart, Lung, and Blood Institute (NHLBI); Foundation of the American Thoracic Society (ATS); American Heart Association (AHA); and Pfizer, Inc.
A debilitating disease, PH is characterized by high blood pressure in the lungs that affects the functioning of the heart and can lead to death from right heart failure. Without treatment, the average survival rate is 2.8 years after diagnosis.
“The PHA Research Committee has finalized what we believe is a comprehensive 2015 portfolio,” said Todd Bull, MD, of the University of Colorado Denver and who chairs PHA’s Research Committee. “The new grants will continue to advance PH research from the early exploratory stages to career development, transitioning new faculty-level investigators to established, independent investigators.”
The 2015 opportunities for which PHA is now seeking applicants include:
PHA/ATS Research Fellowship in PAH – This award enables new faculty-level investigators to make the transition to established investigators. It is a two-year, $80,000 award. Letter of Intent Deadline: June 5, 2015
Robyn Barst Pediatric PH Research and Mentoring Award – A one-year mentorship opportunity for clinicians and researchers in the field of pediatric PH. Three one-year, $50,000 awards will be given in 2015. Funding for these awards is provided by The Joel Belt Pediatric PH Research & Mentoring Grant, Cordelia’s Pediatric PH Research & Mentoring Grant and The Matthew and Michael Wojciechowski Pediatric PH Research & Mentoring Grant through PHA’s named grant program. Letter of Intent Deadline: June 5, 2015
Proof of Concept Award – This award supports new research projects that are in the early exploratory and developmental stages and have the potential to lead to advances in the scientific understanding of PH. At least one $40,000 award will be offered in 2015. Funding for this award is provided by The Jerry Wojciechowski PH Proof of Concept Grant through PHA’s named grant program. Letter of Intent Deadline: June 5, 2015
NHLBI K08/K23 Supplemental Award – This award provides supplemental funding to an individual who receives an NHLBI Mentored Clinical Scientist Development Award (K08) or a Mentored Patient-Oriented Research Career Development Award (K23) for research on PH. One five-year, $312,500 award will be offered in 2015. Application Deadline: July 12, 2015
To apply for the 2015 awards and for more information on PHA’s 2015 grant opportunities, please contact Research(at)PHAssociation(dot)org.
About the Pulmonary Hypertension Association
Headquartered in Silver Spring, Md., with a growing list of chapters across the country, the Pulmonary Hypertension Association (PHA) is the country’s leading pulmonary hypertension organization. Its mission is to find ways to prevent and cure pulmonary hypertension and provide hope for the community through support, education, research, advocacy and awareness. PHA does this by connecting and working together with the entire PH community of patients, families and medical professionals. PHA relies on donations to fund its many programs, including early diagnosis efforts, more than 245 support groups around the country and continuing education for medical professionals. For more information go to PHAssociation.org.
# # #